Stocks To Buy Now

Blog


Laguna Blends, Inc. (LAGBF) Engages QualityStocks Corporate Communications Suite

Laguna Blends, Inc. (OTC: LAGBF), a network marketing company focused on generating sales of its hemp-based functional beverages through independent affiliates, today announced that it has engaged the Corporate Communications Services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value over the past 10 years.

“With the commercialization of our unique, hemp-based beverage products, Laguna Blends is strategically positioned to capture market share in two high-demand markets,” says Laguna Blends CEO Stuart Gray. “As we expand this product line and grow our team of independent sales affiliates, it’s vitally important that we keep shareholders in the loop of our achievements. Working with QualityStocks enables us to continue this growth pattern while fine-tuning our communications strategies.”

QualityStocks will strategically leverage its network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to enhance Laguna Blends’ transparency and brand visibility with the investment community.

“Our objective is to enable Laguna Blends to strengthen its communication initiatives without slowing its pace in terms of growing its sales network, expanding its product line, and building corporate value,” says QualityStocks Managing Director Michael McCarthy. “The QualityStocks team will work closely with Laguna Blends to make sure its corporate message is strong, consistent and visible to both existing and potential shareholders.”

For more information, visit www.lagunablends.com

Let us hear your thoughts: Laguna Blends, Inc. Message Board

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year

February 12, 2026

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity […]

Rotate your device 90° to view site.